Manulife (Manufacturers Life Insurance)’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
15,826
+1,364
| +9% | +$13.1K | ﹤0.01% | 2652 |
|
|
2025
Q1 | $90.7K | Buy |
14,462
+472
| +3% | +$2.96K | ﹤0.01% | 2717 |
|
|
2024
Q4 | $114K | Buy |
13,990
+396
| +3% | +$3.22K | ﹤0.01% | 2793 |
|
|
2024
Q3 | $246K | Sell |
13,594
-347
| -2% | -$6.27K | ﹤0.01% | 2571 |
|
|
2024
Q2 | $144K | Buy |
13,941
+1,339
| +11% | +$13.8K | ﹤0.01% | 2724 |
|
|
2024
Q1 | $134K | Buy |
12,602
+352
| +3% | +$3.74K | ﹤0.01% | 2716 |
|
|
2023
Q4 | $112K | Hold |
12,250
| – | – | ﹤0.01% | 2784 |
|
|
2023
Q3 | $127K | Buy |
12,250
+1,834
| +18% | +$19K | ﹤0.01% | 2731 |
|
|
2023
Q2 | $149K | Buy |
+10,416
| New | +$149K | ﹤0.01% | 2716 |
|
|
2022
Q4 | – | Sell |
-10,080
| Closed | -$112K | – | 2992 |
|
|
2022
Q3 | $112K | Sell |
10,080
-404
| -4% | -$4.48K | ﹤0.01% | 2782 |
|
|
2022
Q2 | $88.5K | Buy |
+10,484
| New | +$88.5K | ﹤0.01% | 2947 |
|
|
2022
Q1 | – | Sell |
-11,443
| Closed | -$225 | – | 3163 |
|
|
2021
Q4 | $225 | Buy |
11,443
+253
| +2% | +$5 | ﹤0.01% | 2827 |
|
|
2021
Q3 | $359K | Sell |
11,190
-699
| -6% | -$22.4K | ﹤0.01% | 2535 |
|
|
2021
Q2 | $402K | Buy |
11,889
+4,765
| +67% | +$161K | ﹤0.01% | 2586 |
|
|
2021
Q1 | $268K | Buy |
7,124
+267
| +4% | +$10K | ﹤0.01% | 2684 |
|
|
2020
Q4 | $228K | Buy |
6,857
+113
| +2% | +$3.76K | ﹤0.01% | 2698 |
|
|
2020
Q3 | $247K | Hold |
6,744
| – | – | ﹤0.01% | 2432 |
|
|
2020
Q2 | $227K | Buy |
+6,744
| New | +$227K | ﹤0.01% | 2433 |
|